Clinical Study on Treatment of Active Liver Cirrhosis with Jiangganlong and Lamivudine

Objective: To study the clinical treating affection of Jiangganlong and Iamivudine. on active liver cirrhosis. Methods: 62 cases of ALC, Were divided into treatment group and control group, randomly. Treatment group was treated with Jiangganlong a dose/3d and Lamivudine 0.1/d; Control group was treated with general treatment for 6 months Results: HBV DNA in the serum changed from positive to negative, the rate of treatment group was 93.32% (28/31), the control group 3.2% (1/31) (P0.01). After treatment, the levels of total bilirubin (TBil)、ALT、 globulin (G) of treatment group were lower and allumin (A) was higher than control group (P0.01). Wide of portal vein, checked with ultrasonic B showed that, the control group was wider than treatment group (P 0.05). Existence rate, treatment group was 93.75 % , compared with control group 74.19% (P0.01). Conclusion: The Effects of traditional herbs medicine with Lamivudine show that, HBV can be impressed, the liver microcirculation can be improved, and hepatic function can be improved, The existence rate of Patients with ALC in treatment group is higher than the control group.